Error: Could not add to watchlist. X
+ Watchlist

Mateon Therapeutics Inc

OXGN:US
Ticker Change
OXGN:US has changed to a new ticker symbol
USD
Volume
0
Previous Close
0.703
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Previous Close
0.703
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.45%
% Price Change
+0.20%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Mateon Therapeutics, Inc. operates as a pharmaceutical company that develops therapeutics to treat cancer and eye diseases. The Company focuses on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.
Address
701 Gateway Blvd
Suite 210
South San Francisco, CA 94080
United States
Phone
1-650-635-7000
Show More